All Relations between dopaminergic and Neurodegenerative Diseases

Publication Sentence Publish Date Extraction Date Species
Hua-Qin Wang, Ryosuke Takahash. Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson's disease. Antioxidants & redox signaling. vol 9. issue 5. 2007-06-04. PMID:17465880. parkinson's disease (pd) is the second most common neurodegenerative disease characterized by selective loss of dopaminergic neurons and the presence of lewy bodies. 2007-06-04 2023-08-12 Not clear
E Ch Wolter. PD-related psychosis: pathophysiology with therapeutical strategies. Journal of neural transmission. Supplementum. issue 71. 2007-05-17. PMID:17447413. parkinson's disease (pd) is a chronic, neurodegenerative disease with degeneration of the central dopaminergic neurons in the substantia nigra, leading to a depletion of dopamine (da) in the striatum. 2007-05-17 2023-08-12 Not clear
Annette E Fleckenstein, Trent J Volz, Evan L Riddle, James W Gibb, Glen R Hanso. New insights into the mechanism of action of amphetamines. Annual review of pharmacology and toxicology. vol 47. 2007-04-10. PMID:17209801. all of these mechanisms have potential implications for both amphetamine- and methamphetamine-induced neurotoxicity, as well as dopaminergic neurodegenerative diseases. 2007-04-10 2023-08-12 Not clear
Marten P Smidt, J Peter H Burbac. How to make a mesodiencephalic dopaminergic neuron. Nature reviews. Neuroscience. vol 8. issue 1. 2007-03-06. PMID:17180160. dopaminergic neurons located in the ventral mesodiencephalon are essential for the control of voluntary movement and the regulation of emotion, and are severely affected in neurodegenerative diseases such as parkinson's disease. 2007-03-06 2023-08-12 mouse
F J Fernandez-Gomez, M D Pastor, E M Garcia-Martinez, R Melero-Fernandez de Mera, M Gou-Fabregas, M Gomez-Lazaro, S Calvo, R M Soler, M F Galindo, J Jordá. Pyruvate protects cerebellar granular cells from 6-hydroxydopamine-induced cytotoxicity by activating the Akt signaling pathway and increasing glutathione peroxidase expression. Neurobiology of disease. vol 24. issue 2. 2007-01-23. PMID:16978869. parkinson disease (pd) is the second-most common age-related neurodegenerative disease and is characterized by the selective destruction of dopaminergic neurons. 2007-01-23 2023-08-12 rat
Shin-ichiro Kubo, Nobutaka Hattori, Yoshikuni Mizun. Recessive Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. vol 21. issue 7. 2006-12-15. PMID:16615060. parkinson's disease (pd) is a progressive neurodegenerative disease caused by loss of dopaminergic neurons in the substantia nigra pars compacta. 2006-12-15 2023-08-12 Not clear
Lorenzo Priano, Maria Rosa Gasco, Alessandro Maur. Transdermal treatment options for neurological disorders: impact on the elderly. Drugs & aging. vol 23. issue 5. 2006-12-05. PMID:16823990. moreover, transdermal dopaminergic drugs, particularly rotigotine, seem the ideal treatment for patients experiencing restless legs syndrome or periodic limb movement disorder during sleep, disorders that are quite common in elderly people or in association with neurodegenerative diseases. 2006-12-05 2023-08-12 Not clear
Ikuko Mizuta, Wataru Satake, Yuko Nakabayashi, Chiyomi Ito, Satoko Suzuki, Yoshio Momose, Yoshitaka Nagai, Akira Oka, Hidetoshi Inoko, Jiro Fukae, Yuko Saito, Motoji Sawabe, Shigeo Murayama, Mitsutoshi Yamamoto, Nobutaka Hattori, Miho Murata, Tatsushi Tod. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. Human molecular genetics. vol 15. issue 7. 2006-09-19. PMID:16500997. parkinson's disease (pd), one of the most common human neurodegenerative diseases, is characterized by the loss of dopaminergic neurons in the substantia nigra of the midbrain. 2006-09-19 2023-08-12 human
Seung U Kim, In H Park, Tae H Kim, Kwang S Kim, Hyun B Choi, Seok H Hong, Jung H Bang, Myung A Lee, In S Joo, Chong S Lee, Yong S Ki. Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease. Neuropathology : official journal of the Japanese Society of Neuropathology. vol 26. issue 2. 2006-06-23. PMID:16708545. parkinson disease is a neurodegenerative disease characterized by loss of midbrain dopaminergic neurons resulting in movement disorder. 2006-06-23 2023-08-12 human
Hitoshi Fukuda, Jun Takahash. Embryonic stem cells as a cell source for treating Parkinson's disease. Expert opinion on biological therapy. vol 5. issue 10. 2006-05-31. PMID:16197334. parkinson's disease (pd) is a neurodegenerative disease characterised by a loss of midbrain dopaminergic (da) neurons. 2006-05-31 2023-08-12 Not clear
Mohamed A Elwan, Jason R Richardson, Thomas S Guillot, W Michael Caudle, Gary W Mille. Pyrethroid pesticide-induced alterations in dopamine transporter function. Toxicology and applied pharmacology. vol 211. issue 3. 2006-04-20. PMID:16005927. parkinson's disease (pd) is a progressive neurodegenerative disease affecting the nigrostriatal dopaminergic pathway. 2006-04-20 2023-08-12 mouse
H Reichman. [Medication treatment for Parkinson's disease]. Der Nervenarzt. vol 76. issue 12. 2006-02-28. PMID:16283151. although parkinsonism is an insidious disease of unknown cause resulting in destruction of important dopaminergic neurons, no other neurodegenerative disease can be treated as successfully. 2006-02-28 2023-08-12 Not clear
J Seibyl, D Jennings, R Tabamo, K Mare. The role of neuroimaging in the early diagnosis and evaluation of Parkinson's disease. Minerva medica. vol 96. issue 5. 2005-12-28. PMID:16227950. nonetheless, current unresolved issues around the clinical role of neuroimaging in monitoring patients over time and validation of quantitative imaging measures of dopaminergic function are immediate issues for the field and the subject of current research efforts and the extension of the lessons learned in parkinson's to other neurodegenerative diseases including alzheimer's dementia. 2005-12-28 2023-08-12 human
Stacy S Wu, Steven J Fruch. Treatment of Parkinson's disease : what's on the horizon? CNS drugs. vol 19. issue 9. 2005-11-07. PMID:16142989. although great strides have been made in the development of agents to treat this neurodegenerative disease, none yet address the underlying problem associated with it, the progressive loss of dopaminergic neurons. 2005-11-07 2023-08-12 Not clear
Charleen T Chu, Jian-hui Zhu, Guodong Cao, Armando Signore, Suping Wang, Jun Che. Apoptosis inducing factor mediates caspase-independent 1-methyl-4-phenylpyridinium toxicity in dopaminergic cells. Journal of neurochemistry. vol 94. issue 6. 2005-10-27. PMID:16156740. parkinson's disease is a debilitating neurodegenerative disease characterized by loss of midbrain dopaminergic neurons. 2005-10-27 2023-08-12 mouse
Dong-Youn Hwang, Sheila M Fleming, Paul Ardayfio, Taylor Moran-Gates, Hansoo Kim, Frank I Tarazi, Marie-Francoise Chesselet, Kwang-Soo Ki. 3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 25. issue 8. 2005-10-26. PMID:15728853. parkinson's disease (pd) is a neurodegenerative disease characterized by a loss of dopaminergic neurons in the substantia nigra. 2005-10-26 2023-08-12 mouse
Emiliana Borrell. Without DJ-1, the D2 receptor doesn't play. Neuron. vol 45. issue 4. 2005-04-25. PMID:15721232. parkinson's disease and parkinsonism are neurodegenerative diseases of dopaminergic neurons affecting the human brain. 2005-04-25 2023-08-12 human
Pavan K Auluck, Marc C Meulener, Nancy M Bonin. Mechanisms of Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin in Drosophila. The Journal of biological chemistry. vol 280. issue 4. 2005-03-08. PMID:15556931. parkinson's disease is a common neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta and the accumulation of the protein alpha-synuclein into aggregates called lewy bodies and lewy neurites. 2005-03-08 2023-08-12 drosophila_melanogaster
Masato Asanuma, Ikuko Miyazaki, Francisco J Diaz-Corrales, Norio Ogaw. Quinone formation as dopaminergic neuron-specific oxidative stress in the pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism. Acta medica Okayama. vol 58. issue 5. 2005-02-08. PMID:15666991. parkinson's disease (pd) is a progressive neurodegenerative disease characterized by dopaminergic neuron-specific degeneration in the substantia nigra. 2005-02-08 2023-08-12 Not clear
Marco Cosentino, Emanuela Rasini, Cristina Colombo, Franca Marino, Fabio Blandini, Marco Ferrari, Alberta Samuele, Sergio Lecchini, Giuseppe Nappi, Gianmario Frig. Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: evidence for a D1-like receptor-dependent protective effect. Free radical biology & medicine. vol 36. issue 10. 2004-11-23. PMID:15110388. the present findings add knowledge about the sensitivity of pbl to da and strengthen the rationale for exploiting these cells as an easily accessible peripheral model for the ex vivo investigation of oxidative stress-related dopaminergic mechanisms underlying human neurodegenerative diseases. 2004-11-23 2023-08-12 human